0001209191-23-000935.txt : 20230104
0001209191-23-000935.hdr.sgml : 20230104
20230104162518
ACCESSION NUMBER: 0001209191-23-000935
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230101
FILED AS OF DATE: 20230104
DATE AS OF CHANGE: 20230104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DesJardin Michael A.
CENTRAL INDEX KEY: 0001512985
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35238
FILM NUMBER: 23506823
MAIL ADDRESS:
STREET 1: C/O JAZZ PHARMACEUTICALS, INC.
STREET 2: 3180 PORTER DRIVE
CITY: PALO ALTO
STATE: CA
ZIP: 94304
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co
CENTRAL INDEX KEY: 0001492426
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
BUSINESS PHONE: 011-353-1-772-2100
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
FORMER COMPANY:
FORMER CONFORMED NAME: Horizon Pharma plc
DATE OF NAME CHANGE: 20140919
FORMER COMPANY:
FORMER CONFORMED NAME: HORIZON PHARMA, INC.
DATE OF NAME CHANGE: 20100520
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-01
0
0001492426
Horizon Therapeutics Public Ltd Co
HZNP
0001512985
DesJardin Michael A.
C/O HORIZON THERAPEUTICS PLC,
70 ST. STEPHEN?S GREEN
DUBLIN
L2
D02 E2X4
IRELAND
0
1
0
0
EVP, Technical Operations
Ordinary Shares
2023-01-01
4
M
0
21772
A
104395
D
Ordinary Shares
2023-01-01
4
F
0
9561
113.80
D
94834
D
Performance Restricted Stock Units (PSUs)
2023-01-01
4
M
0
21772
0.00
D
Ordinary Shares
21772
0
D
Each PSU represents a contingent right to receive one ordinary share of the Issuer.
The ordinary shares subject to the PSUs vested on January 1, 2023.
/s/ Patrick McIlvenny, Attorney-in-Fact
2023-01-04